First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
about
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
First-in-human trial of multik ...... b in advanced cancer patients.
@ast
First-in-human trial of multik ...... b in advanced cancer patients.
@en
type
label
First-in-human trial of multik ...... b in advanced cancer patients.
@ast
First-in-human trial of multik ...... b in advanced cancer patients.
@en
prefLabel
First-in-human trial of multik ...... b in advanced cancer patients.
@ast
First-in-human trial of multik ...... b in advanced cancer patients.
@en
P2093
P2860
P50
P1433
P1476
First-in-human trial of multik ...... b in advanced cancer patients.
@en
P2093
Adrienne Johnson
Alexa B Schrock
Behrang Amini
Daniel D Karp
David Fabrizio
David S Hong
Gerald S Falchook
James X Sun
P2860
P356
10.1172/JCI.INSIGHT.90380
P577
2017-04-20T00:00:00Z